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ABSTRACT Microwave ablation (MWA) is a promising treatment option for patients suffering from
liver cancer utilizing electromagnetic wave heating within the targeted tissue at microwave frequencies.
Knowledge about the dielectric properties of the targeted tissues is essential for the design of recent MWA
systems by including treatment monitoring possibilities. This work focuses on the evaluation of the patient-
specific dielectric contrast between healthy and diseased liver parts at discrete frequencies at 2.45GHz and
5.8GHz, as well as a broadband data analysis. Measurements yield a frequency-dependent dielectric contrast
with local maxima for each patient. Due to large variations between the dielectric properties of the patients,
the need for individual thresholds can be derived to distinguish between healthy and malignant tissue.
INDEX TERMS Dielectric properties of liver, microwave ablation, tumor tissue.
I. INTRODUCTION
The use of microwave technologies and techniques for
medical applications leads to novel methods for diagnostics
and treatment options. By increasing the frequency up to
the gigahertz regime, the propagating electromagnetic (EM)
waves interact with the targeted tissue in a contact-less
and nondestructive way. For the development and optimiza-
tion of advanced microwave devices, the knowledge about
dielectric properties of human tissue is essential. Regard-
ing diagnostic methods, the detection of solid tumors is
a possible application where microwave technology could
be an adequate complement to existing imaging modalities
such as radiography, Computer Tomography (CT), Ultra-
sound (US) and Magnetic Resonance Imaging (MRI). For
breast cancer detection, the non-ionizing microwave imag-
ing concept shows promising results and could be used
for preventive examinations of women [1], [2]. But also as
treatment monitoring tool for microwave ablation (MWA)
therapy, microwave tomography could be a suitable candi-
date [3]. MWA is a minimally invasive technique performed
under imaging guidance with the main goal to eradicate
malignancies plus a safety margin of 5mm via heat. The
treatment option is commonly used for hepatic tumors such
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as hepatocellular carcinoma (HCC), which is the second
most common cause of cancer-related mortality in the world
[4]. For a considerable large number of primary and sec-
ondary liver cancers, the surgical resection is not possible [5].
Consequently, minimal-invasive interventional approaches
could be applied. Beside MWA, alternative treatment
options are radiofrequency ablation (RFA), laser-induced-
thermotherapy (LITT), cryoablation, transarterial chemoem-
bolization, and stereotactic radiotherapy [6]. Advantages of
MWA compared to other methods are higher ablation vol-
umes in a shorter treatment duration and a reduced sus-
ceptibility to the heat-sink effect. However, the demand for
treatment monitoring tools for MWA to improve existing sys-
tems is high [7]. Beside microwave tomography as treatment
monitoring tool, advanced MWA applicators were proposed
in [8]–[10]. Those devices are able tomeasure the permittivity
of the surrounding tissue to detect changes of electromagnetic
properties due to tumor-healthy tissue boundaries. For this
reason, a-priori knowledge about the dielectric properties of
tumor and healthy tissue is of particular interest for the design
and optimization of novel microwave applicators. Further-
more, temperature induced effects on the permittivity could
bemonitored to enable a treatment feedback for the practicing
radiologist. With increasing temperature, the permittivity of
tissue decreases. At very high temperatures over 90 ◦C such as
it occurs during microwave ablation treatments, the dielectric
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properties drop dramatically and continue to decrease with
time of exposure [11], [12].
Various studies that investigate dielectric properties of
human tissues were conducted. The majority of measure-
ments were performed with ex-vivo tissue samples due
to challenging establishment of suitable protocols for in-
vivo measurements. In [13], a comprehensive study on the
dielectric properties of several biological tissues in the fre-
quency range from 10Hz to 20GHz is presented and further
processed by a parametric model in [14]. The complex per-
mittivity of liver cancer tissue for the lower microwave fre-
quency range from 50MHz to 900MHz was investigated
in [15]. In [16], the dielectric properties of human liver
were characterized including samples of primary hepatocel-
lular carcinoma, metastatic colorectal carcinoma, and normal
tissue over the frequency range from 0.3GHz to 3GHz.
To meet the demand of knowledge about higher frequency
dispersion behavior of liver tissue, the characterization of
human normal, malignant and cirrohotic liver tissue up to
20GHz is presented in [17]. The proposed study included
six patients with either HCC or hepatic metastases who
underwent hepatic resection surgeries. Beside the measure-
ments of freshly excised ex-vivo liver samples, the complex
permittivity of in-vivo liver was also determined. The col-
lected data was evaluated at two single-frequency points at
915MHz and 2.45GHz that are commonly used for MWA
devices. Moreover, a broadband data analysis was conducted
by fitting the ex-vivo measurement data to a single-pole
Cole-Cole model. In-vivo liver data could not be represented
by a Cole-Cole model, and further, shows an unexpected
dispersion trend over 15GHz. In [18], variations in dielec-
tric properties of malignant and healthy human liver tis-
sues of six patients were examined in the frequency range
between 0.1GHz and 5GHz.The study comprises an anal-
ysis of the permittivity data per patient with the focus on
a comparison of the data from different tumor types and
a more in-depth discussion about corresponding underlying
pathological states of tissue. Furthermore, an analysis of the
more recent data from [18] compared to older published
data yields that the dielectric properties reported in [17]
are generally on higher side compared to all other reported
values.
In this work, the complex permittivity of ex-vivo human
liver samples from hepatic resections is measured including
normal andmalignant tissue parts from 0.5MHz to 26.5GHz.
In contrast to previously mentioned studies, the data anal-
ysis is focused on the patient-specific dielectric contrast
between normal and diseased tissue parts of liver sam-
ples. Based on these results, sensitivity requirements on
novel microwave devices for hepatic cancer detection can
be derived. In Section II, the study procedure and measure-
ment setup is described. Further, the concept is presented
how the permittivity data is evaluated and analyzed. The
single-frequency and broadband dielectric contrast results
are shown and discussed in Section III. Finally, the work is
concluded in Section IV.
II. MATERIALS AND METHODS
The dielectric contrast of normal and malignant liver tissue
per patient is of particular importance to verify the feasi-
bility of microwave-based hepatic tumor detection systems.
Therefore, dielectric measurements of native, freshly excised
human liver samples containing healthy and diseased parts
from hepatic resection surgeries at J. W. Goethe- Univer-
sity Hospital Frankfurt, Germany, were performed. For the
experiments involving the use of human subjects, an ethi-
cal approval was obtained from the ethics committee of the
J. W. Goethe- University Hospital. The samples were trans-
ported from the operating room to the pathology to cut the
tissue into slices and mark healthy and diseased tissue parts.
The prepared samples were then transported to the measure-
ment laboratories at the Institute of Diagnostic and Inter-
ventional Radiology (IDIR). A non-sealed petri dish within
a polystyrene box without additional preservative material
was used for transportation. The total time from the resection
of the liver sample to the first measurement was less than
one hour. Patients with contagious liver diseases were not
included in the study.
A. MEASUREMENT SETUP
The microwave measurement system consists of a portable
vector network analyzer (PXI M9375A, Keysight Technolo-
gies) suitable for measurements up to 26.5GHz and the
commercial Slim Form probe (85070E Dielectric Probe Kit,
Keysight Technologies) based on an open-ended coaxial
structure with an outer diameter of 2.16mm. The setup is
shown in Fig 1(a). Generally, open-ended coaxial probes are
widely used for the characterization of dielectric properties
from biological tissues [19], [20]. The coaxial probe gen-
erates a quasi-static capacitor-like field whose interrogation
can be directly correlated to the dielectric properties of the
surrounding Material under test (MUT). The region close to
the open end of the probe has a higher influence on the result-
ing measured permittivity compared to regions farther away
from the tip. For this reason, the aim for sample preparation
is to obtain samples that are as homogeneous as possible
within the sensing area of the probe. To ensure a complete
electric field absorption in the MUT, the minimum thickness
of all tissue samples was 5mm. Since fringing fields around
the coaxial probe are neglectable small, the sensing area is
limited to te region where the probe tip touches the MUT.
An example of a liver sample with healthy and tumor tissue
parts is given in Fig. 1 (b) and (c). The coaxial probe was
connected to the VNA with a 90◦ angled adapter to provide a
preferably stable phase condition during the measurements.
Furthermore, the setup included mechanical components.
An elevating platform was placed on a digital balance to
position the MUT right under the dielectric probe. With
this, a repeatable pressure for each measurement sample was
obtained. The dielectric properties of theMUTwere extracted
from one-port reflection measurements by applying a cali-
bration procedure that directly maps the measured reflection
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FIGURE 1. (a) Measurement setup consisting of VNA and dielectric probe, example of liver sample including (b) healthy and (c) diseased tissue
parts.
coefficient to the complex permittivity plane that was exten-
sively investigated in literature, for example in [21], [22]. The
measurements were controlled by a routine in Matlab (The
Mathworks Inc.) that guides the user through the calibration,
initiates reflection measurements, and monitors the extracted
permittivity values of the MUT in real-time. The dielectric
probe is calibrated with the standard loads, namely deionized
water (DIW), short, and open. Reflection measurements of
the coaxial probe inserted in DIW, loaded with a metallic
device that is part of the Dielectric Probe Kit, and surrounded
by air were conducted. By knowing the complex permittivity
values of these standard loads, the bilinear relation between
the measured reflection coefficient and permittivity of the
MUT can be solved. The accuracy of the applied calibration
procedure and proposed measurement system yields a mea-
surement bias within 5% [23]. The dielectric measurements
were conducted in the frequency range from 500MHz to
26.5GHz with 2001 equidistantly distributed measurements
points and an IF bandwidth of 100Hz. One measurement
took around 50 s. In order to ensure reproducibility of the
procedure, two consecutive measurements were performed
for each location of the dielectric probe on the sample. For
further analysis, the average value of the two consecutive
measurements corresponds to one measurement, since they
practically overlap. All measurements were performed at an
ambient temperature of 21 ◦C±1 ◦C. The drift of the calibra-
tion with time was evaluated by measuring the permittivity of
the reference liquid DIW before and after the tissue sample
measurements of each patient. For the real part of the relative
permittivity ε′r, the drift is below 1.3% along the whole
spectrum. The measurements of the imaginary part ε′′r yield
a mean drift of 12.3% for the frequency range below 2GHz
and above that frequency, the drift decreased to 1%.
B. DATA ANALYSIS
The dielectric properties of biological tissue are mainly
characterized by polarization mechanisms. In the frequency
range from 0.5GHz to 26.5GHz, the dominant polarization
TABLE 1. Number of measurements for ex-vivo human liver samples.
mechanism is the dipolar orientation of water molecules. The
loss mechanisms in tissue lead to a complex form of the
relative permittivity ε∗r
ε∗r = ε′r − jε′′r . (1)
The differences between the permittivity of normal and
malignant tissue are evaluated at distinct frequencies as well
as along the whole frequency spectrum for each patient. For
the analysis, 2.45GHz as widely used operation frequency
for MWA systems is considered. Further, we evaluated dif-
ferences at 5.8GHz that is located within the next higher
ISM band and could be used to realize higher frequency
ablation devices. For the broadband analysis of the dielectric
contrast between the malignant and normal tissue parts for
each patient the real and imaginary part of the measured
permittivity data is taken into account. Hence, we define the
dielectric contrast 1 as
1 =
∣∣∣∣∣∣ε∗Tumor − ε∗Normal
ε∗Normal
∣∣∣∣∣∣ (2)
III. MEASUREMENT RESULTS
Within the proposed study, measurements of liver sam-
ples from five patients were conducted. Depending on the
respected sample size, 2-9 locations were measured on nor-
mal and malignant tissue parts. In total, 30 measurement
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FIGURE 2. Mean value and standard deviation from complex permittivity of normal and tumor measurements per patient at (a), (c) 2.45GHz and
(b), (d) 5.8GHz.
points in tumor tissue and 33 measurements in normal tissue
were included in the study. Measurements of cirrhotic and
necrotic liver were not included in the study. According to
the pathological findings, all patients in the study suffered
from a fatty liver. A summary of the measurement points and
histology of the resected liver samples including the degree
of steatosis is given in Table 1. In the following, the patient-
specific dielectric contrast is evaluated at two single frequen-
cies, 2.45GHz and 5.8GHz, and over the frequency spectrum
from 0.5GHz to 26.5GHz.
A. SINGLE-FREQUENCY DIELECTRIC CONTRAST
Figure 2 shows the mean value and standard deviation of the
real and imaginary part of the permittivity for each patient at
2.45GHz and 5.8GHz. The permittivity trends observed for
2.45GHz and 5.8GHz are very similar. Generally, the differ-
ence between normal and malignant measurement points are
higher compared to the corresponding standard variations of
the measurements. That indicates a possible discrimination
between healthy and diseased tissue parts per patient. Only
patient 3 exhibits an exceptional large standard deviation of
the measurements in normal tissue. A possible explanation
could be the presence of tumor cells within the tissue stated
as healthy. For all other patients, the standard variation of
normal measurements is smaller compared to tumor mea-
surements. This supports the assumption that liver presents
a homogeneous tissue structure compared to other tissue
parts. The determination of a general threshold value over all
patients to distinguish between healthy and diseased tissue is
not possible due to the large variations of permittivity values
from patient to patient. Therefore, measurements of the actual
patient-specific dielectric contrast is needed for the detection
of tumors with microwave imaging devices.
The permittivity difference between normal and malignant
tissue samples ranges from 20.9% to 34.3% for the real part
ε′r and 17.3% to 35.8% for the imaginary part ε′′r . Those
values are comparable to the data reported in [17] where
the relative permittivity and the effective conductivity of
malignant tissue at 2.45GHz were found to be 20% and 18%
higher than normal tissue, respectively. The slightly larger
difference between the mean dielectric properties of normal
and tumor tissue from this study can be attributed to the
widespread fatty liver samples.
B. BROADBAND DIELECTRIC CONTRAST
The dielectric contrast 1 according to Eq. (2) is determined
for each patient. Therefore, we used the mean value of the
measured complex permittivity of normal and tumor tissue,
respectively. As a result, five curves are generated that depict
the contrast1 in % as a function of frequency in Fig. 3. It can
be observed that the dielectric contrast presents a very high
variation for different patients.While the maximum dielectric
contrast of patient 3 is 28.9%, patient 2 shows a maximum
dielectric contrast of 60.9%. The patient specific dielectric
contrast exhibits a frequency dependency with a maximum at
11.37GHz, 12.56GHz, 11.91GHz, 9.24GHz, and 7.85GHz
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FIGURE 3. Dielectric contrast 1 between normal and tumor tissue as a function of frequency for all five patients.
for patients 1, 2, 3, 4, and 5, respectively. The patients can be
separated in two groups representing a high dielectric contrast
above 50% and medium dielectric contrast below this value.
Due to the limited number of patients, no relation between
primary or secondary cancer type and the dielectric contrast
can be observed.
Possible physiological explanations for the increased
dielectric properties of tumor compared to normal tissue
are a higher sodium and water content of tumor cells [18].
The fact that we observe a frequency where the dielectric
contrast reaches a local maximum indicates the presence of
a certain relaxation process in tissue that might be related
to the increased water content in tumor cells. Regarding
the sensitivity requirements for treatment monitoring tools
utilizing microwave techniques, the results reveal a certain
frequency range between 8GHz to 12GHz with maximum
dielectric contrasts. However, the question if the frequency
range is also optimal for the realization of those devices must
be further investigated. Due to the physical limitations of
electromagnetic field penetrations with increasing frequency,
sensing devices utilizing the proposed frequency range would
have very limited penetration depths.
IV. CONCLUSION
Permittivity measurement in the frequency range between
0.5GHz to 26.5GHz of freshly excised human liver cancer
samples from five patients were performed. The data analysis
focused on the evaluation of the patient-specific dielectric
contrast between healthy and diseased liver tissue at discrete
frequencies at 2.45GHz and 5.8GHz and over the whole
measured frequency spectrum.
The evaluation of patient-specific dielectric contrasts
yielded a high variation between the patients with maximum
values between 28.9% and 60.9%. The presence of a local
maximum in the range of the relaxation frequency of the
measured permittivity is an evidence that dipolar polarization
mechanisms mainly attribute to the differences between nor-
mal and tumor tissues in liver. Further, themeasured dielectric
contrast were larger compared to the variance of each sample.
As a result, the discrimination between healthy and diseased
tissue parts would be possible by measuring patient-specific
permittivity values. In particular, advanced MWA systems
with sensing capabilities andmicrowave tomography systems
could benefit from these findings.
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